1. Continued misuse of orphan drug legislation: a life-threatening risk for mexiletine. (1st February 2020) Authors: Postema, Pieter G; Schwartz, Peter J; Arbelo, Elena; Bannenberg, Wilbert J; Behr, Elijah R; Belhassen, Bernard; Brugada, Josep; Brugada, Pedro; John Camm, A; Casado-Arroyo, Ruben; 't Hoen, Ellen; Hollak, Carla E M; Kääb, Stefan; Lambiase, Pier D; Leenhardt, Antoine; Priori, Silvia G; Probst, Vinc... Journal: European heart journal Issue: Volume 41:Number 5(2020) Page Start: 614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. N-of-1 trial of salbutamol in hyperkalaemic periodic paralysis. Issue 12 (10th June 2021) Authors: Stunnenberg, Bas C; Merkus, Esther C; Raaphorst, Joost; Saris, Christiaan GJ; Groenewoud, Hans; Statland, Jeffrey; Weijma, Robyn; van Vlijmen, Bas; Griggs, Robert; van Engelen, Baziel G M; van der Wilt, Gert Jan Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 92:Issue 12(2021) Page Start: 1352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗